Promising Preclinical Results for MYC Inhibition in Melanoma
Cutaneous melanoma, the most aggressive form of skin cancer, is the fifth most diagnosed cancer in Europe and one of the most frequent causes of
Promising Preclinical Results for MYC Inhibition in Melanoma
